Massachusetts General Hospital

Name

Massachusetts General Hospital

Legal name

Massachusetts General Hospital

Website

https://massgeneral.org

Company type

Private

Founded year

1811

Operating status

Operating

Headcount range

5,001–10,000 employees

Ownership category

akta.pro rank

Product category

Academic Medical Center Services

NAICS

General Medical and Surgical Hospitals (6221)

SIC

Services-General Medical & Surgical Hospitals, Nec (8062)

akta.pro primary industry

Academic Medical Centers (AMCs) & Teaching Hospitals (HLAFAAAA)

akta.pro secondary industry

Academic Medical Centers & Teaching Hospitals (University-Affiliated) (EDAHAGAA)

Keywords

• Academic medical center
• Hospital clinical services
• Medical research programs
• Medical education training
• Specialty care centers

Headquarters

HQ city

Boston

HQ country

United States

HQ region

North America

Offices14 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Clinical Care Services: Revenue from providing direct patient care services including hospital stays, procedures, diagnostic tests, and outpatient consultations. Massachusetts General Hospital accepts most health insurance plans including Medicare and Medicaid.
2. Research Grants and Funding: External research funding from foundations, pharmaceutical companies, government agencies, and healthcare organizations for clinical research and drug development programs.
3. Clinical Trial Collaborations: Pharmaceutical partnerships for conducting clinical trials, including drug development collaborations with companies such as Tonix Pharmaceuticals, Keros Therapeutics, Quantum BioPharma, and others.
4. Education and Training: As the original teaching hospital of Harvard Medical School, revenue is generated through medical education programs, residencies, and fellowships.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels6 records

Core offering

Massachusetts General Hospital is the original and largest teaching hospital of Harvard Medical School, providing comprehensive inpatient, outpatient, and emergency clinical care across 30+ centers and departments including cancer, cardiovascular, neurosurgery, and primary care. The hospital operates the largest hospital-based research program in the United States, conducting clinical trials, biomedical research, and translational science. As part of Mass General Brigham, it also delivers medical education through residencies and fellowships, supported by nearly 3,000 physicians across 53 locations in the Boston area.

Product overview

Massachusetts General Hospital is a major academic medical center offering comprehensive healthcare services through multiple specialized departments and centers. The hospital operates Patient Gateway, a secure digital patient portal, alongside its clinical care programs including the Mass General Brigham Cancer Institute, Corrigan Minehan Heart Center, neurosurgery, interventional radiology, and primary care services. The institution conducts clinical trials and research collaborations while providing patient care across numerous medical specialties. The hospital is recognized as a top hospital on the U.S. News & World Report Best Hospitals Honor Roll for 2025-2026 and is the original and largest teaching hospital of Harvard Medical School.

Differentiator

Problem solved

Functional benefit

Products and services

• Mass General Brigham Patient Gateway Secure online patient portal providing 24/7 access to health information, appointment scheduling and management, secure messaging with providers, prescription renewal requests, and online bill payment for Mass General patients.
• Mass General Brigham Cancer Institute Comprehensive cancer center providing diagnostic, treatment, and survivorship services across all cancer types, including access to clinical trials, CAR-T cell therapy, proton therapy, and specialized programs such as the Multiple Myeloma Center.
• Corrigan Minehan Heart Center Comprehensive cardiovascular center providing diagnosis, interventional procedures, surgery, and cardiac rehabilitation for heart and vascular conditions.
• Fireman Vascular Center Comprehensive vascular center providing treatment for arterial, venous, and lymphatic conditions, including endovascular and open surgical interventions, co-directed by the Chief of Vascular and Endovascular Surgery.
• Department of Neurosurgery Comprehensive neurosurgery department performing more than 4,300 procedures annually, including cerebrovascular, endovascular, spinal, tumor, and functional neurosurgery, supported by interventional neuroradiology and brain-computer interface research programs.
• Transplant Center Comprehensive solid organ transplant center providing evaluation, surgery, and post-transplant care for kidney, liver, heart, lung, and other organ transplants.
• Emergency Department Level 1 trauma and emergency department providing 24/7 emergency care at the Boston main campus.
• Primary Care Services Comprehensive primary care services delivered through multiple practice locations across the Boston area, including adult and pediatric primary care, same-day urgent care for current patients, and population health management programs.
• Concierge Medicine Program Membership-based primary care service providing dedicated physician access and personalized care at the Boston main campus on an annual subscription basis.
• Virtual Visits (Telehealth) Telehealth service allowing patients to meet with Mass General providers remotely via computer or phone for consultations and follow-up care.
• International Patient Services Dedicated concierge-style service coordinating care for international patients seeking specialized treatment at MGH, including multilingual interpretation, travel logistics support, and care coordination across the Boston campus and satellite locations.
• Clinical Trials Program Clinical trials portfolio spanning Phase 1-3 studies across multiple therapeutic areas, including oncology, neurology, ALS, multiple sclerosis, and rare diseases, operated in collaboration with pharmaceutical and biotech sponsors and foundations.
• Medical Education and Training Programs Graduate medical education programs including residencies, fellowships, and continuing medical education delivered as the primary teaching hospital of Harvard Medical School.
• Interventional Radiology Services Image-guided interventional radiology services including uterine fibroid embolization, interventional neuroradiology, endovascular neurosurgery, and other minimally invasive procedures at the Boston main campus and the Waltham outpatient location.

Quantifiable outcome

• BCI enables typing at 22 words per minute, nearly matching smartphone texting speed
• +3 more outcomes

Named customers6 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability25 records

Feature7 records

Partnerships

17 partnerships are on record, tiered minor and core.

• Diakonos OncologyminorStrategic or Co-development Partner · 5 June 2026Phase 1/2 DOC-RM study evaluating DOC1021 dendritic cell immunotherapy in refractory melanoma patients who progressed after anti-PD-1 therapy, with enrollment active at Mass General.
• Samsung ElectronicscoreStrategic or Co-development Partner · 27 May 2026Joint clinical study to investigate whether Galaxy Watch can help monitor and manage muscle loss in patients undergoing GLP-1RA therapy. Study enrolls 100 adults starting weight-loss medication, with intervention group using Galaxy Watch8 for body composition tracking via Bioelectrical Impedance Analysis.
• Tonix PharmaceuticalscoreStrategic or Co-development Partner · 27 May 2026Phase 2 investigator-initiated study of TNX-1500 (anti-CD40L monoclonal antibody) in kidney transplant recipients expected at MGH in H2 2026 pending FDA IND clearance. Study will assess safety in preventing organ rejection.
• Quantum BioPharma Ltd.coreStrategic or Co-development Partner · 18 May 2026Collaborative PET imaging study to validate novel PET tracer [¹⁸F]3F4AP for assessing demyelination in multiple sclerosis patients. Study reached halfway mark in enrollment with encouraging preliminary imaging results.
• Trethera CorporationcoreStrategic or Co-development Partner · 31 March 2026Clinical collaboration to evaluate TRE-515 in up to six patients with advanced ALS under FDA Expanded Access program, assessing safety, tolerability, and disease trajectory.
• Paradromics Inc.coreStrategic or Co-development Partner · 27 March 2026APEX Partnership Program for advancing brain-computer interface technology leveraging Paradromics' Connexus BCI platform capable of 200+ bits per second transfer rate with single-neuron resolution.
• Alzamend NeurocoreStrategic or Co-development Partner · 16 March 2026Phase II clinical trial evaluating AL001 novel lithium-delivery system in patients with Bipolar Disorder type 1, comparing against lithium carbonate using MRI/MRS neuroimaging to assess pharmacokinetics.
• Keros Therapeutics / Sean M. Healey & AMG Center for ALScoreStrategic or Co-development Partner · 9 March 2026Collaboration to design Phase 2 trial evaluating rinvatercept for ALS within the Healey ALS MyMatch program, a biomarker-driven personalized trial matching ALS patient subgroups to experimental therapies.
• Immunai Inc.minorStrategic or Co-development Partner · 12 January 2026Selected as part of Immunai's Grand Collaboration Initiative for Single-Cell Immune Profiling, receiving free single-cell RNA sequencing to support research in immunotherapy resistance in gastric cancer.
• Inflammasome TherapeuticscoreStrategic or Co-development Partner · 18 November 2025Partnership to advance K9 (kamuvudine-9) oral therapy into Phase 1b/2a clinical trials under Healey ALS MyMatch program. Preclinical experiments showed K9 reduced neurofilament light chain levels by 80%.
• SoundHealthminorStrategic or Co-development Partner · 18 November 2025Development collaboration for Spatial Sleep, an FDA-registered personalized acoustic sleep headband using AI and machine learning, with 90% of users showing significant sleep improvement in clinical trials.
• Tonix PharmaceuticalsminorStrategic or Co-development Partner · 22 October 2025First patient dosed in FOCUS study evaluating intranasal potentiated oxytocin for Arginine-Vasopressin Deficiency (AVP-D) at MGH.
• Siemens HealthineerscoreStrategic or Co-development Partner · 30 September 2025Strategic collaboration to create Therapy Command Center for theranostics research, utilizing radiopharmaceuticals and advanced PET/CT scanners to study radiation's impact on molecular processes.
• Debbie's Dream FoundationminorStrategic or Co-development Partner · 31 December 2024$250,000 research grant to study treatment resistance in gastric cancer patients with malignant ascites, aiming to improve treatment options by understanding immune system interference.
• Fireside ProjectminorStrategic or Co-development PartnerMGH received IRB approval for clinical study evaluating psychedelic coaching as an adjunct to standard ketamine care for depression at the hospital's ketamine clinic in Boston.
• L'Oréal Dermatological Beauty / CeraVeminorStrategic or Co-development PartnerAnnouncement of first-ever endowed chair in global health dermatology, the L'Oréal Dermatological Beauty/CeraVe Endowed Chair, with Dr. Esther E. Freeman appointed as inaugural chair.
• NovartisminorStrategic or Co-development PartnerResearch collaboration with investigators including Merit Cudkowicz at MGH for tofersen (Qalsody), FDA-approved ALS treatment for SOD1 genetic variant patients.

Scale indicators9 records

Recent moves6 records

Expansion highlights7 records

Direct peers

• Brigham and Women's Hospital: Co-flagship academic medical center within the Mass General Brigham system and Harvard Medical School's other major teaching hospital. Directly comparable in scope (research-intensive AMC, Harvard affiliation, complex specialty care) and competes with MGH for patients, faculty, and research funding in the same Boston market.
• Mayo Clinic: Top-ranked AMC globally (ranked #1 per Newsweek 2026) and MGH's primary national peer in complex care, research output, and brand reputation. Operates as a nonprofit integrated AMC with comparable multispecialty clinical and research missions.
• Cleveland Clinic: Ranked #3 globally and operates as a comparable nonprofit AMC with major research enterprise, multispecialty clinical care, and international patient services. Direct competitor for complex case referrals and brand leadership.
• Johns Hopkins Hospital: Top-ranked AMC with integrated medical school (Johns Hopkins University School of Medicine), comparable research scale, and similar Harvard-tier brand in academic medicine. Direct competitor in NIH research funding and complex specialty care.
• NewYork-Presbyterian Hospital: Major nonprofit AMC affiliated with Columbia and Cornell medical schools. Comparable in scale, complexity of cases, research output, and role as a regional referral destination serving the Northeast.
• UCSF Medical Center: University-affiliated AMC with leading NIH-funded research program and high-complexity care delivery. Comparable in research intensity, specialty breadth, and academic medical center operating model on the West Coast.
• Stanford Health Care: Stanford University-affiliated AMC with strong biomedical research enterprise and tertiary/quaternary care delivery. Comparable in translational research pipeline, complex specialty services, and ability to attract top medical talent.
• UCLA Health: David Geffen School of Medicine-affiliated AMC with comparable research scale, comprehensive specialty services, and academic medical center operating model. Direct competitor for complex specialty referrals and clinical research partnerships.
• Hospital of the University of Pennsylvania (Penn Medicine): Perelman School of Medicine-affiliated AMC with strong research output and high-complexity care delivery. Comparable in research intensity, AMC cost structure, and academic ranking among U.S. News Honor Roll peers.
• Beth Israel Deaconess Medical Center: Harvard Medical School-affiliated AMC located in Boston, ranked #112 globally per Newsweek. Direct local competitor for complex cases, faculty recruitment, and NIH research funding within the same Boston market and Harvard ecosystem.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks4 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/watch?v=4ElY-RyFMlQ
• Facebookfacebook.com/MassGeneralInternational
• LinkedInlinkedin.com/company/massachusetts-general-hospital
• Xx.com/MassGeneralNews

Revenue estimate

Valuation estimate

Number of profiles

Profiles14 records

Funding overview

Funding rounds9 records

Investors9 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments2 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Massachusetts General Hospital